NL-OMON46544已完成不适用
Clinical pharmacoloGy of platinUm-based hyperThermic intraperitoneal chemotherapy: exploration of the impact of flushing on tumOur, systemic and personnel eXposure - GUTOX
Afdeling Apotheek0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Patients with a confirmed diagnosis of preoperatively identified primary or recurrent peritoneal carcinomatosis of colorectal origin who are planned for HIPEC treatment with oxaliplatin according to routine clinical care
- •2. Patient is at least 18 at the day of screening.
- •3. Patient is able and willing to sign the lnformed Consent Form.
- •4. Patient is able and willing to follow protocol requirements.
排除标准
- •There are no specific exclusion criteria.
研究者
相似试验
已完成
不适用
Safety and efficacy of heated chemotherapy given during surgery in management of gall bladder cancerCTRI/2018/02/011879I45
已完成
不适用
Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal ChemotherapyPeritoneal CarcinomatosisNCT03364907Radboud University Medical Center20
已完成
1 期
Phase I/II Trial of a novel mild hyperthermia using Oncothermia (EHY-2000) and TS-1/Docetaxel in the treatment of peritoneal metastatic gastric cancerGastric cancerJPRN-UMIN000022420Chiba University33
进行中（未招募）
不适用
Performance and Safety of thermotherapy with nanoparticles (NanoTherm® Therapy System) as an adjuvant therapy to the Standard of Care treatment of patients with recurrent glioblastomaC71.9Brain, unspecifiedDRKS00023339MagForce AG5
尚未招募
不适用
Study of Intraperitoneal chemotherapy in gastric cancer:CTRI/2018/01/011056AIIMS